PDF) Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant
L 150b - 2009-10 - Endeligt svar på spørgsmål 1: Spm. om, hvilke andre former for legater, der ydes på baggrund af en påskønnelsesværdig og/eller almenvelgørende indsats, indgår efter gældende regler i
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant. - Abstract - Europe PMC
Rehabilitering af synsfunktion efter hjerneskade - ppt download
High Prevalence of Human Anti‐bovine IgG Antibodies as the Major Cause of False Positive Reactions in Two‐Site Immunoassays Based on Monoclonal Antibodies: Journal of Immunoassay and Immunochemistry: Vol 25, No 1
ALLE SPONSORER
PDF) Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor
Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor | Journal of Neuroscience
Projekter – Instituttet for Blinde og Svagsynede
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant. - Abstract - Europe PMC
Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor | Journal of Neuroscience
Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor | Journal of Neuroscience
DELTAG I NVT-PROJEKT
IBOS Standard
Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor | Journal of Neuroscience
Projekter – Instituttet for Blinde og Svagsynede
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant. - Abstract - Europe PMC
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant. - Abstract - Europe PMC
XSL•FO
PDF) Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor
PDF) Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant
